Actavis Pharma Inc.
Actavis Pharma Inc., a prominent player in the global pharmaceutical industry, is headquartered in the United States. Founded in 1984, the company has established itself as a leader in generic and specialty pharmaceuticals, focusing on areas such as central nervous system disorders, cardiovascular health, and infectious diseases. With a robust portfolio of core products, Actavis is renowned for its commitment to quality and innovation, offering a wide range of generic medications that provide cost-effective alternatives to brand-name drugs. The company has achieved significant milestones, including strategic acquisitions that have expanded its market presence and product offerings. Actavis Pharma Inc. continues to strengthen its position in the competitive pharmaceutical landscape, recognised for its dedication to improving patient access to essential medications while maintaining high standards of safety and efficacy.
DitchCarbon Score
How does Actavis Pharma Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Actavis Pharma Inc.'s score of 37 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Actavis Pharma Inc.'s reported carbon emissions
Actavis Pharma Inc., headquartered in the US, currently does not have publicly available data regarding its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that the company may not have established formal commitments to reduce its carbon footprint or engage in climate action strategies at this time. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and emissions reduction, highlighting the importance of transparency and accountability in environmental practices.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Actavis Pharma Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
